- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 279/24 - [b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
Patent holdings for IPC class C07D 279/24
Total number of patents in this class: 16
10-year publication summary
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5816 |
2 |
| Centre National de La Recherche Scientifique | 10128 |
1 |
| Acenda Pharma, Inc. | 2 |
1 |
| Cellceutix Corporation | 11 |
1 |
| Colorado State University Research Foundation | 696 |
1 |
| Gentex Corporation | 1883 |
1 |
| Immungenetics AG | 9 |
1 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2657 |
1 |
| Kyushu University, National University Corporation | 1633 |
1 |
| Nagasaki University | 199 |
1 |
| Power OLEDs Limited | 3 |
1 |
| The Regents of the University of Colorado, a body corporate | 2573 |
1 |
| Universidad de Concepcion | 114 |
1 |
| Universite Paris Descartes | 378 |
1 |
| Enrock Pharmaceutical Technologies (Hebei) Limited | 3 |
1 |
| Other owners | 0 |